Sequent Medical has announced that it has completed patient enrolment in its Investigational Device Exemption (IDE) pivotal trial to evaluate the safety and effectiveness of the WEB Aneurysm Embolisation System.
The phenox pREset and pREset LITE thrombectomy devices have been included in the study portfolio of the SITS Open clinical trial. Two other devices are included in the trial.
New data from two separate studies looking at the use of the NeuroBlate system from Monteris for brain lesions were presented at the American Association of Neurological Surgeons (AANS) 84th Annual Scientific Meeting.
The US Patent and Trademark Office (USPTO) has approved a patent providing additional coverage of Neuravi’s therapeutic stent-retriever platform for the endovascular treatment of acute ischaemic stroke. Earlier this year, Neuravi also received a European patent grant for this platform.
Brainlab has enrolled 11, to date, of the expected 30 hospitals and healthcare systems in the national Stereotactic Radiosurgery (SRS) Patient Registry.
Winner of the Louise Eisenhardt Traveling Scholarship, Sophia F Shakur, presented her research—Changes in Pulsatility and Resistance Indices of Cerebral Arteriovenous Malformation Feeder Arteries after Embolization and Surgery—during the 2016 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
Abbott is set to acquire St Jude Medical, expanding its portfolio to cover cardiovascular markets such as atrial fibrillation, structural heart and heart failure as well as neuromodulation. The combined company will thus produce devices across cardiovascular, diabetes, vision and neuromodulation markets.
In a study evaluating the safety and feasibility of a combination of proximal internal carotid artery occlusion using a balloon catheter and distal aspiration through an intermediate catheter in stroke patients treated with mechanical thrombectomy with a stent retriever, the investigators report that there was no macroscopic thrombus migration to a new vascular territory.
A new study has concluded that burst spinal cord stimulation is “in general” more effective than tonic stimulation in patients already familiar with spinal cord stimulation.
After a stroke, there is inflammation in the damaged part of the brain. Until now, the inflammation has been seen as a negative consequence that needs to be abolished as soon as possible. But, as it turns out, there are also some positive sides to the inflammation, and it can actually help the brain to self-repair.
As chronic traumatic encephalopathy stands in the national spotlight for high impact sports, the University of California, Irvine has partnered with Toshiba America Medical Systems for a first-of-its-kind study of cerebral microbleeds in high school football players as a potential precursor to chronic traumatic encephalopathy. The study will utilise Toshiba’s Vantage Titan 3T MR system as the key diagnostic tool, taking advantage of its non-invasive capabilities.
Amnis Therapeutics has announced successful results in its pre-clinical trials, which tested the safety and efficacy of the Golden Retriever neuro thrombectomy device. The safety trial was conducted in Israel, while the efficacy trial was conducted in a US lab.
More than 40% of retired National Football League (NFL) players in a recent study had signs of traumatic brain injury based on sensitive MRI scans called diffusion tensor imaging, according to a study that will be presented at the American Academy of Neurology’s 68th Annual Meeting (15–21 April, Vancouver, Canada).
The Zika virus may be associated with an autoimmune disorder that attacks the brain’s myelin similar to multiple sclerosis, according to a small study that will be presented at the American Academy of Neurology’s 68th Annual Meeting (15–21 April, Vancouver, Canada).
Investigators have found that with strict adherence to top tier evidence criteria, half of ischaemic stroke patients with emergent large vessel occlusion (ELVO) may not be considered for mechanical thrombectomy even though according to their data, there is no increased risk of symptomatic intracerebral haemorrhage (sICH) and higher mortality is largely linked to occlusions in the basilar artery and patients treated at an extended time window.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos